Related Experiment Video
Updated: Nov 17, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Hepatitis B Virus: From Diagnosis to Treatment
Meryem Guvenir1, Ayse Arikan2,3
1Near East University, Vocational School of Health Services, Nicosia, Northern Cyprus.
Insights
Hepatitis B screening is vital for pregnant women and high-risk adults. Early diagnosis via serological and molecular tests, followed by antiviral treatment, significantly improves outcomes for chronic hepatitis B patients.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis B infection remains a significant global health issue, leading to chronic hepatitis, liver failure, and mortality.
- Transmission primarily occurs from infected mothers to children and through infected blood and body fluids.
Purpose of the Study:
- To highlight the importance of screening for Hepatitis B infection in pregnant women, adolescents, and high-risk adults.
- To outline diagnostic approaches for differentiating acute and chronic Hepatitis B.
- To emphasize the necessity of monitoring and antiviral treatment for chronic Hepatitis B.
Main Methods:
- Initial diagnosis involves serological tests to distinguish between acute and chronic hepatitis.
- Molecular assays are employed for viral DNA detection, quantification, genotyping, and drug resistance analysis.
- Precore/core mutation analysis aids in confirming infection and monitoring disease progression.
Main Results:
- Serological tests effectively differentiate acute from chronic hepatitis B.
- Molecular assays provide comprehensive data for infection confirmation and disease management.
- Antiviral therapies, including nucleos(t)ide analogs and pegylated interferons, are crucial for managing chronic Hepatitis B.
Conclusions:
- Regular screening and early diagnosis of Hepatitis B are essential for at-risk populations.
- A combination of serological and molecular diagnostics ensures accurate assessment and monitoring.
- Effective antiviral treatment and regular monitoring of chronic Hepatitis B patients reduce mortality and disease progression.
Abstract:
Hepatitis B infection is still a global concern progressing as acute-chronic hepatitis, severe liver failure, and death. The infection is most widely transmitted from the infected mother to a child, with infected blood and body fluids. Pregnant women, adolescents, and all adults at high risk of chronic infection are recommended to be screened for hepatitis B infection. The initial analysis includes serological tests that allow differentiation of acute and chronic hepatitis. Molecular assays performed provide detection and quantification of viral DNA, genotyping, drug resistance, and precore/core mutation analysis to confirm infection and monitor disease progression in chronic hepatitis B patients. All patients with chronic hepatitis B should be treated with antiviral medications and regularly monitored for efficient treatment. The current treatment is based on nucleos(t)ide analogs and pegylated interferons that save lives by decreasing liver cancer death, liver transplant, slow or reverse the progression of liver disease as well as the virus infectivity.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Retrovirus Life Cycles